Biofrontera Inc. (BFRI)
USD 0.84
(0.17%)
USD 0.84
(0.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -22.67 Million USD | 4.6% |
| 2022 | -22.38 Million USD | 13.42% |
| 2021 | -25.85 Million USD | -210.19% |
| 2020 | -8.33 Million USD | 44.15% |
| 2019 | -14.92 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.07 Million USD | 7.24% |
| 2024 Q1 | -5.46 Million USD | -41.45% |
| 2023 Q3 | -4.62 Million USD | 46.89% |
| 2023 FY | -21.35 Million USD | 4.6% |
| 2023 Q4 | -3.86 Million USD | 16.34% |
| 2023 Q2 | -8.69 Million USD | -52.83% |
| 2023 Q1 | -5.69 Million USD | -6.99% |
| 2022 Q2 | -8.11 Million USD | -160.84% |
| 2022 Q1 | -3.11 Million USD | -65.43% |
| 2022 FY | -22.38 Million USD | 13.42% |
| 2022 Q4 | -5.32 Million USD | 8.89% |
| 2022 Q3 | -5.83 Million USD | 28.02% |
| 2021 FY | -25.85 Million USD | -210.19% |
| 2021 Q4 | -1.88 Million USD | 88.33% |
| 2021 Q3 | -16.1 Million USD | -336.8% |
| 2021 Q2 | -3.68 Million USD | -4.51% |
| 2021 Q1 | -3.52 Million USD | -1776.6% |
| 2020 Q2 | -2.5 Million USD | 33.04% |
| 2020 FY | -8.33 Million USD | 44.15% |
| 2020 Q4 | -188 Thousand USD | 91.98% |
| 2020 Q3 | -2.34 Million USD | 6.58% |
| 2020 Q1 | -3.74 Million USD | 0.0% |
| 2019 FY | -14.92 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 113.582% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -801.592% |
| Embecta Corp. | 221.5 Million USD | 110.238% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 125.865% |
| PainReform Ltd. | -9.58 Million USD | -136.613% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -373.889% |
| SCYNEXIS, Inc. | 72.66 Million USD | 131.206% |
| Journey Medical Corporation | -2.07 Million USD | -993.922% |
| Safety Shot Inc | -12.18 Million USD | -86.119% |
| Alpha Teknova, Inc. | -35.56 Million USD | 36.234% |
| Bright Green Corporation | -8.89 Million USD | -155.045% |
| Procaps Group, S.A. | 38.97 Million USD | 158.186% |
| Alvotech | -354.86 Million USD | 93.61% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 148.279% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -50.159% |
| Cosmos Health Inc. | -21.83 Million USD | -3.874% |
| Dynavax Technologies Corporation | -37.02 Million USD | 38.757% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 85.423% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 85.772% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -373.889% |
| Theratechnologies Inc. | -10.62 Million USD | -113.39% |
| Harrow Health, Inc. | 580 Thousand USD | 4009.828% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -382.387% |
| DURECT Corporation | -36.88 Million USD | 38.518% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -330.385% |
| Cronos Group Inc. | -81.37 Million USD | 72.133% |
| OptiNose, Inc. | -22.74 Million USD | 0.312% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 110.848% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 42.081% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 279.52% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 281.054% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -422.955% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -265.121% |
| Radius Health, Inc. | -3.92 Million USD | -477.758% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -542.996% |
| ProPhase Labs, Inc. | -21.61 Million USD | -4.923% |
| Phibro Animal Health Corporation | 53.31 Million USD | 142.534% |
| Procaps Group S.A. | 52.32 Million USD | 143.34% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -166.068% |
| Viatris Inc. | 766.2 Million USD | 102.96% |
| Rockwell Medical, Inc. | -6.67 Million USD | -239.985% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -331.614% |
| SIGA Technologies, Inc. | 83.62 Million USD | 127.119% |
| Tilray Brands, Inc. | -174.74 Million USD | 87.023% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 343.029% |
| Shineco, Inc. | -17.06 Million USD | -32.879% |
| PetIQ, Inc. | 60.01 Million USD | 137.786% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -378.748% |
| Incannex Healthcare Limited | -30.04 Million USD | 24.513% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 109.038% |
| Alimera Sciences, Inc. | -1.47 Million USD | -1441.604% |
| Silver Spike Investment Corp. | 7.34 Million USD | 408.946% |
| Assertio Holdings, Inc. | -243.53 Million USD | 90.688% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -284.853% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -66.53% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | -45.421% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -13.102% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 83.549% |
| Hempacco Co., Inc. | -8.81 Million USD | -157.334% |
| Talphera, Inc. | -16.88 Million USD | -34.271% |
| Alvotech | -354.86 Million USD | 93.61% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 142.423% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 106.219% |
| Currenc Group, Inc. | -6.64 Million USD | -241.224% |
| Kamada Ltd. | 10.06 Million USD | 325.328% |
| Indivior PLC | -4 Million USD | -466.925% |
| Evoke Pharma, Inc. | -7.43 Million USD | -205.172% |
| Flora Growth Corp. | -50.35 Million USD | 54.965% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -13.102% |
| Evolus, Inc. | -49.23 Million USD | 53.939% |
| HUTCHMED (China) Limited | 18.37 Million USD | 223.412% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 111.512% |
| Akanda Corp. | -10.05 Million USD | -125.611% |